A critical review on neonatal hyperbilirubinemia-an Ayurvedic perspective

Shubhangi Rathore1, Chethan Kumar Vk1, Sharashchandra R1

  • 1Department of Kaumarabhritya, Shri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Udupi, Karnataka, India.

Insights

Neonatal hyperbilirubinemia, or newborn jaundice, is caused by high bilirubin levels. Ayurvedic principles offer insights into its pathology, linking it to imbalances like Pittaja stanya dushti.

Area of Science:

  • Neonatal Medicine
  • Ayurvedic Medicine

Background:

  • Neonatal hyperbilirubinemia involves elevated bilirubin levels in newborns, causing jaundice.
  • It stems from increased red blood cell breakdown and immature liver function.
  • Key factors include increased bilirubin production, reduced liver clearance, and enhanced enterohepatic circulation.

Purpose of the Study:

  • To explore the Ayurvedic perspective on neonatal jaundice pathology.
  • To correlate neonatal hyperbilirubinemia with the Ayurvedic concept of 'kamala'.

Main Methods:

  • Review of Ayurvedic texts, specifically Kashyapa Samhita.
  • Analysis of neonatal jaundice pathophysiology through Ayurvedic principles (dosha, dhatu, mala, srotas).

Main Results:

  • Ayurveda provides a framework to understand neonatal jaundice through 'Pittaja stanya dushti'.
  • The study links physiological variations in newborns to elevated unconjugated bilirubin levels within an Ayurvedic context.

Conclusions:

  • Ayurvedic principles offer a unique understanding of neonatal jaundice.
  • Integrating Ayurvedic concepts can enhance pediatricians' knowledge of neonatal hyperbilirubinemia.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
163
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
184
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
154
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
227
Bronsted-Lowry Acids and Bases02:58

Bronsted-Lowry Acids and Bases

The acid-base reaction class has been studied for quite some time. In 1680, Robert Boyle reported traits of acid solutions that included their ability to dissolve many substances, to change the colors of certain natural dyes, and to lose these traits after coming in contact with alkali (base) solutions. In the eighteenth century, it was recognized that acids have a sour taste, react with limestone to liberate a gaseous substance (now known to be CO2), and interact with alkalis to form neutral...
102.6K